1673-422X
2012 Issue 5
Astrocyte elevated gene 1 in malignant tumor
DU Cheng;XIE Xiao-dong
DU Cheng;XIE Xiao-dong
..............page:341-344
Mechanisms of oxaliplatin neurotoxicity and its predictions
WANG Yang;LI Ji-sheng;WANG Xiu-wen
WANG Yang;LI Ji-sheng;WANG Xiu-wen
..............page:366-369
Epithelial-mesenchymal transition in digestive system tumors
XU Chun-hong;ZOU Xiao-ping
XU Chun-hong;ZOU Xiao-ping
..............page:380-383
Exhaled volatile organic compounds detection in cancer diagnosis
HONG Jian;XIA Hai-long
HONG Jian;XIA Hai-long
..............page:370-373
Expression of COX-2 and survivin protein in elderly patients with gastric cancer and its metastasis and prognosis
GU Hua-ping;SHANG Pei-zhong
GU Hua-ping;SHANG Pei-zhong
..............page:387-390
Regulation of cyclin E and cancers
GUO Cui-ping;ZHANG Guo-jun
GUO Cui-ping;ZHANG Guo-jun
..............page:337-340
Drug resistance related factors and cancer metastasis
HUANG Zi-qi;LU Lie-sheng;DING Wei-xing
HUANG Zi-qi;LU Lie-sheng;DING Wei-xing
..............page:359-362
Mechanism and treatment associated with resistance to EGFR-TKI
XU Qiu-yi;MOU Hai-bo;XU Nong
XU Qiu-yi;MOU Hai-bo;XU Nong
..............page:355-359
Treatment of recurrent small cell lung cancer
SHAO Lan;ZHANG Yi-ping
SHAO Lan;ZHANG Yi-ping
..............page:373-376
Autophagy and cancer
WANG Jun;ZOU Xiao-ping
WANG Jun;ZOU Xiao-ping
..............page:323-326
Angiopoietin-2 and tumor angiogenesis
ZHENG An-hong;ZHANG Wei-dong
ZHENG An-hong;ZHANG Wei-dong
..............page:352-355
Anti-tumor clinical research of mTOR inhibitor
LI Xu-yuan;LIN Ying-cheng
LI Xu-yuan;LIN Ying-cheng
..............page:363-366
MicroRNA and cancer
QIU Zhen-hua;GAO Yan;WANG Mao-sheng;JI De-lin
QIU Zhen-hua;GAO Yan;WANG Mao-sheng;JI De-lin
..............page:333-337
Basal-like breast cancer
LI Sheng-lan;ZHANG Qing-yuan
LI Sheng-lan;ZHANG Qing-yuan
..............page:377-380
Cytokine-induced killer cells in cancer treatment
HANG Xue-feng;DING Zhen-yu;XIE Xiao-dong
HANG Xue-feng;DING Zhen-yu;XIE Xiao-dong
..............page:344-347
Cyclin D1 G870A polymorphism and the risk of colorectal cancer: a systematic review
ZOU Xi;ZHANG Wei-jian;HONG Jin-sheng;LIU Feng;CAI Chuan-shu;WANG Pei-rong;CHEN De-qin
ZOU Xi;ZHANG Wei-jian;HONG Jin-sheng;LIU Feng;CAI Chuan-shu;WANG Pei-rong;CHEN De-qin
..............page:395-400
Hepatocyte growth factor and its receptor in multiple myeloma
HU Cheng-lin;FU Lei-hua;CHEN Lin
HU Cheng-lin;FU Lei-hua;CHEN Lin
..............page:384-386
Neoplasms-associated autophagy signaling pathways
LIN Sheng-ming;XIANG Jian-feng;ZHANG Min-guang
LIN Sheng-ming;XIANG Jian-feng;ZHANG Min-guang
..............page:326-329
Advances of miR-221/222 in tumors
DONG Ling-yi;ZHANG Hui;YE Ying-jiang
DONG Ling-yi;ZHANG Hui;YE Ying-jiang
..............page:330-333
..............page:后插2
Dosimetric difference in RapidArc planning for radiotherapy of multiple hepatic malignancy using different photon energy
GONG Guan-zhong;YIN Yong;ZHAI De-yin;LIU Tong-hai;SONG Jin-long;LU Jie;CHEN Jin-hu;WANG Ruo-zheng
GONG Guan-zhong;YIN Yong;ZHAI De-yin;LIU Tong-hai;SONG Jin-long;LU Jie;CHEN Jin-hu;WANG Ruo-zheng
..............page:391-395
Anti-tumor mechanism of CIK cells and research
WANG Chun-hua;HE Yi-fu;HU Bing
WANG Chun-hua;HE Yi-fu;HU Bing
..............page:348-351